文献速递先天性心脏病外科

远程缺血预处理不能预防新生儿白质损伤

Remote Ischemic Preconditioning Does Not Prevent White Matter Injury in Neonates.
PubMed 文献 · Ann Thorac Surg · 2018-03-28

该随机、盲法临床试验纳入67例接受体外循环先天性心脏病修复术的新生儿,随机分为远程缺血预处理(RIPC)组33例与假处理(SHAM)组34例,以术前至术后脑磁共振成像白质损伤体积变化为结局。RIPC组白质损伤平均变化600 mL³,SHAM组107 mL³,两组白质损伤患病率无差异(p > 0.5),白质损伤变化均值无显著差异(p = 0.178)。结论认为无证据表明RIPC在此类新生儿中提供神经保护。

要点

  • 67例新生儿随机分组,RIPC组33例、SHAM组34例,50例有可评估的术前术后MRI。
  • 白质损伤患病率术前28%、术后62%,按治疗组比较无差异(p > 0.5)。
  • RIPC组白质损伤平均变化600 mL³ vs SHAM组107 mL³,无显著差异(p = 0.178)。

核心结论

  • 在这项随机、盲法临床试验中,无证据表明使用RIPC在接受体外循环先天性心脏缺损修复术的新生儿中提供神经保护。

研究设计与样本

  • 随机、盲法临床试验,纳入67例接受体外循环先天性心脏病修复术的新生儿,随机分为RIPC组33例与SHAM组34例。
  • RIPC在体外循环前通过血压袖带充气四个5分钟循环造成下肢缺血诱导;SHAM组放置袖带但不充气。
  • 结局为白质损伤,通过术前至术后脑磁共振成像的白质损伤体积变化评估。
  • 50例患者有可评估的术前和术后MRI,包括RIPC组33例中的26例和SHAM组34例中的24例。

主要发现

  • 总体研究组及可评估MRI组中,两组基线和手术特征均无差异。
  • 白质损伤在术前28%的患者中被识别,术后62%的患者中被识别。
  • 按治疗组比较白质损伤患病率无差异(p > 0.5)。
  • RIPC组白质损伤平均变化为600 mL³,SHAM组平均白质损伤变化为107 mL³。
  • 接受RIPC与接受SHAM治疗的患者之间白质损伤变化均值无显著差异(p = 0.178)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Remote ischemic preconditioning (RIPC) is a mechanism to protect tissues from injury during ischemia and reperfusion. We investigated the neuroprotective effects of RIPC in neonates undergoing cardiac surgery. METHODS: The outcome was white matter injury (WMI), assessed by the change in volume of WMI from preoperative to postoperative brain magnetic resonance imaging (MRI). Patients were randomized to RIPC or SHAM. RIPC was induced prior to cardiopulmonary bypass by four 5-minute cycles of blood pressure cuff inflation to produce ischemia of the lower extremity. For patients randomized to SHAM, the cuff was positioned, but not inflated. RESULTS: The study included 67 patients, with 33 randomized to RIPC and 34 randomized to SHAM. Preoperative and postoperative MRIs were available in 50 patients, including 26 of the 33 RIPC patients and 24 of the 34 SHAM patients. There were no differences in baseline and operative characteristics for either the overall study group or the group with evaluable MRIs. WMI was identified in 28% of the patients preoperatively and in 62% postoperatively. There was no difference in the prevalence of WMI by treatment group (p > 0.5). RIPC patients had an average change in WMI of 600 mL3, and SHAM subjects had an average WMI change of 107 mL3. There was no significant difference in the mean value of WMI change between patients who received RIPC and those who received SHAM treatments (p = 0.178). CONCLUSIONS: In this randomized, blinded clinical trial, there was no evidence that use of RIPC provides neuroprotection in neonates undergoing repair of congenital heart defects with cardiopulmonary bypass.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Gaynor JW, Nicolson SC, Spray DM, et al. Remote Ischemic Preconditioning Does Not Prevent White Matter Injury in Neonates. Ann Thorac Surg. 2018. PMID: 29601806. doi:10.1016/j.athoracsur.2018.02.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。